BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 38385078)

  • 1. M7G-related tumor immunity: novel insights of RNA modification and potential therapeutic targets.
    Han M; Huang Q; Li X; Chen X; Zhu H; Pan Y; Zhang B
    Int J Biol Sci; 2024; 20(4):1238-1255. PubMed ID: 38385078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological roles of RNA m7G modification and its implications in cancer.
    Zhang X; Zhu WY; Shen SY; Shen JH; Chen XD
    Biol Direct; 2023 Sep; 18(1):58. PubMed ID: 37710294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
    Li T; Chen Z; Wang Z; Lu J; Chen D
    Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of N
    Luo Y; Yao Y; Wu P; Zi X; Sun N; He J
    J Hematol Oncol; 2022 May; 15(1):63. PubMed ID: 35590385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N7-methylguanosine modification: from regulatory roles to therapeutic implications in cancer.
    Cai M; Yang C; Wang Z
    Am J Cancer Res; 2023; 13(5):1640-1655. PubMed ID: 37293166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal m7G methylation: A novel epitranscriptomic contributor in brain development and diseases.
    Xia X; Wang Y; Zheng JC
    Mol Ther Nucleic Acids; 2023 Mar; 31():295-308. PubMed ID: 36726408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
    Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis from multi-center studies identities m7G-derived modification pattern and risk stratification system in skin cutaneous melanoma.
    Zhang X; Miao Y; Sun HW; Wang YX; Zhao WM; Pang AY; Wu XY; Shen CC; Chen XD
    Front Immunol; 2022; 13():1034516. PubMed ID: 36532001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
    Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M
    Front Oncol; 2022; 12():1055605. PubMed ID: 36761423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern and prognostic value of key regulators for N7-methylguanosine RNA modification in prostate cancer.
    Zhai Q; Hou Y; Ye Y; Dai S; Guo G; Yang Q; Pang G; Wei Q
    Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):561-573. PubMed ID: 36810782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Profiling of N7-Methylguanosine Modification of Messenger RNA in Drug-Resistant Acute Myeloid Leukemia.
    Zhang B; Li D; Wang R
    Front Oncol; 2022; 12():926296. PubMed ID: 35865472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of N
    Ma X; Yang B; Yang Y; Wu G; Ma X; Yu X; Li Y; Wang Y; Guo Q
    Front Genet; 2022; 13():946845. PubMed ID: 36105111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome-Wide Dynamics of m7G-Related LncRNAs during the Progression from HBV Infection to Hepatocellular Carcinoma.
    Shi M; Zhu S; Sun L; Hu J; Li H; Dai W; Song N; Li M; Wu Y; Xu D; Guo T
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):339. PubMed ID: 38179760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
    He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
    Front Genet; 2022; 13():998147. PubMed ID: 36226166
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct N7-methylguanosine profiles of circular RNAs in drug-resistant acute myeloid leukemia.
    Fu J; Si L; Zhou Y; Li D; Wang R
    Sci Rep; 2023 Sep; 13(1):14704. PubMed ID: 37679400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Landscape of internal N7-methylguanosine of long non-coding RNA modifications in resistant acute myeloid leukemia.
    Han J; Liu Q; Zhou Y; Li D; Wang R
    BMC Genomics; 2023 Jul; 24(1):425. PubMed ID: 37501118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel m7G regulator-based methylation patterns in head and neck squamous cell carcinoma.
    Ying Y; Zhang W; Zhu H; Luo J; Xu X; Yang S; Zhao Y; Zhang Z
    Mol Carcinog; 2023 Dec; 62(12):1902-1917. PubMed ID: 37642290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis.
    Wang H; Chen RB; Zhang SN; Zhang RF
    BMC Genomics; 2022 Jan; 23(1):33. PubMed ID: 34996349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy.
    Wei W; Liu C; Wang C; Wang M; Jiang W; Zhou Y; Zhang S
    Front Genet; 2022; 13():1016797. PubMed ID: 36339001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.